DJO Incorporated (DJO) Misses Q3 Views
More News related to DJO
- Standard & Poor's Changes to U.S. Indices
- DJO Incorporated (DJO) Misses Q3 Views
- DJO Incorporated (DJO) Receives FDA Approval for Supplement to Company's Existing Pre-Market Approval
- DJO Incorporated (DJO) Receives Accreditation Status by Accreditation Commission for Health Care
- Blackstone (BX) Gets Antitrust OK For DJO Inc (DJO) Buyout - DJ
DJO Incorporated (NYSE: DJO) reports Q3 adj-EPS of $0.34, below the consensus of $0.39. Revenues came in at $119.8 million versus the consensus of $121.8 million.
DJO Incorporated is a provider of solutions for musculoskeletal and vascular health, specializing in rehabilitation and regeneration products for the non-operative orthopedic, spine and vascular markets.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
